SKYSTAR BIO-PHARMACEUTICAL CO Net Income
SKYSTAR BIO-PHARMACEUTICAL CO reported Net Income of $4.91 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO net income (loss) attributable to parent for the quarter ending 2014-09-30 was $4.91M, a 31.47% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net income (loss) attributable to parent for the quarter ending 2014-06-30 was $2.81M, a 25.06% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net income (loss) attributable to parent for the quarter ending 2014-03-31 was $975.45K, a 36.86% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO net income (loss) attributable to parent for the quarter ending 2013-12-31 was $2.33M.
- SKYSTAR BIO-PHARMACEUTICAL CO net income (loss) attributable to parent for fiscal 2013 was $10.53M, a 69.50% increase from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO net income (loss) attributable to parent for fiscal 2012 was $6.21M, a 54.51% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO net income (loss) attributable to parent for fiscal 2011 was $13.66M, a 3.08% decline from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO net income (loss) attributable to parent for fiscal 2010 was $14.09M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2014-09-30 | $4.91M 10-Q · filed 2014-11-14 | $7.72M derived: sum of 2 quarters · filed 2014-11-14 | $8.70M 10-Q · filed 2014-11-14 | $11.03M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $2.81M 10-Q · filed 2014-08-14 | $3.79M 10-Q · filed 2014-08-14 | $6.12M derived: sum of 3 quarters · filed 2014-08-14 | $9.85M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $975.45K 10-Q · filed 2014-05-15 | $3.31M derived: sum of 2 quarters · filed 2014-05-15 | $7.04M derived: sum of 3 quarters · filed 2014-11-14 | $10.79M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $6.07M derived: sum of 2 quarters · filed 2014-11-14 | $9.82M derived: sum of 3 quarters · filed 2014-11-14 | $10.53M 10-K · filed 2014-03-31 |
| 2013-09-30 | $3.73M 10-Q · filed 2014-11-14 | $7.49M derived: sum of 2 quarters · filed 2014-11-14 | $8.20M 10-Q · filed 2014-11-14 | $8.08M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $3.75M 10-Q · filed 2014-08-14 | $4.46M 10-Q · filed 2014-08-14 | $4.34M derived: sum of 3 quarters · filed 2014-08-14 | $7.07M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $712.73K 10-Q · filed 2014-05-15 | $590.29K derived: sum of 2 quarters · filed 2014-05-15 | $3.32M derived: sum of 3 quarters · filed 2014-05-15 | $5.02M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | -$122.45K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $2.61M derived: sum of 2 quarters · filed 2014-03-31 | $4.31M derived: sum of 3 quarters · filed 2014-03-31 | $6.21M 10-K · filed 2014-03-31 |
| 2012-09-30 | $2.73M 10-Q · filed 2013-11-14 | $4.43M derived: sum of 2 quarters · filed 2013-11-14 | $6.33M 10-Q · filed 2013-11-14 | $8.83M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $1.70M 10-Q · filed 2013-08-14 | $3.60M 10-Q · filed 2013-08-14 | $6.09M derived: sum of 3 quarters · filed 2013-08-14 | $13.82M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $1.90M 10-Q · filed 2013-05-15 | $4.40M derived: sum of 2 quarters · filed 2013-05-15 | $12.12M derived: sum of 3 quarters · filed 2013-05-15 | $13.63M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $10.22M derived: sum of 2 quarters · filed 2013-04-01 | $11.73M derived: sum of 3 quarters · filed 2013-04-01 | $13.66M 10-K · filed 2013-04-01 |
| 2011-09-30 | $7.73M 10-Q · filed 2012-11-14 | $9.24M derived: sum of 2 quarters · filed 2012-11-14 | $11.17M 10-Q · filed 2012-11-14 | $15.14M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $1.51M 10-Q/A · filed 2012-09-13 | $3.44M 10-Q/A · filed 2012-09-13 | $7.41M derived: sum of 3 quarters · filed 2012-09-13 | $14.06M derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $1.93M 10-Q · filed 2012-05-15 | $5.90M derived: sum of 2 quarters · filed 2012-05-15 | $12.55M derived: sum of 3 quarters · filed 2012-05-15 | $14.93M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $10.62M derived: sum of 2 quarters · filed 2012-03-30 | $13.00M derived: sum of 3 quarters · filed 2012-03-30 | $14.09M 10-K · filed 2012-03-30 |
| 2010-09-30 | $6.65M 10-Q · filed 2011-11-14 | $9.03M derived: sum of 2 quarters · filed 2011-11-14 | $10.12M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $2.38M 10-Q/A · filed 2011-09-21 | $3.47M 10-Q/A · filed 2011-09-21 |